Tingyan Shi
Overview
Explore the profile of Tingyan Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang R, Feng Y, Chen Y, Cheng X, Shi T, Gao W, et al.
Nat Med
. 2024 Jun;
30(8):2181-2188.
PMID: 38824243
Surgery for platinum-sensitive, relapsed ovarian cancer (PSROC) is widely practiced but had contradictory survival outcomes in previous studies. In this multicenter, open-label, phase 3 trial, women with PSROC, and having...
2.
Zhang C, Xu Y, Zhu X, Zhang X, Wang F, Hu L, et al.
Oncogene
. 2024 May;
43(26):1985-1999.
PMID: 38734828
Ovarian cancer is one of the most common gynecological malignant tumors with insidious onset, strong invasiveness, and poor prognosis. Metabolic alteration, particularly aerobic glycolysis, which is tightly regulated by transcription...
3.
Shi T, Liu J, Zhu J, Wang X, Jiang W, Lu X, et al.
Chin Med J (Engl)
. 2024 Apr;
137(14):1744-1746.
PMID: 38654409
No abstract available.
4.
Yang X, Hu X, Yin J, Li W, Fu Y, Yang B, et al.
Nat Commun
. 2024 Mar;
15(1):2089.
PMID: 38453961
Hyperthermic intraperitoneal chemotherapy's role in ovarian cancer remains controversial, hindered by limited understanding of hyperthermia-induced tumor cellular changes. This limits developing potent combinatory strategies anchored in hyperthermic intraperitoneal therapy (HIPET)....
5.
Shen P, Ye K, Xiang H, Zhang Z, He Q, Zhang X, et al.
Sci Adv
. 2023 Nov;
9(47):eadj0123.
PMID: 37992178
Transcriptional dysregulation is a recurring pathogenic hallmark and an emerging therapeutic vulnerability in ovarian cancer. Here, we demonstrated that ovarian cancer exhibited a unique dependency on the regulatory machinery of...
6.
Fan W, Xiong R, Zhou Z, Zhang C, Han Y, Shi T, et al.
J Cancer
. 2023 Jul;
14(11):2039-2050.
PMID: 37497403
Ovarian cancer (OC) which is one of the frequently-occurring gynecologic malignant tumors, endangers the health of women. The zinc finger protein 57 (ZFP57) plays crucial functions during the progression of...
7.
Ma X, Zhou W, Zhang R, Zhang C, Yan J, Feng J, et al.
Mater Today Bio
. 2023 Jun;
20:100663.
PMID: 37273798
Photodynamic therapy (PDT) induces immunogenic cell death (ICD) by producing reactive oxygen species (ROS), making it an ideal method for cancer treatment. However, the extremely lower level of oxygen, short...
8.
Lu B, Liu C, Qi J, He W, Shi T, Zhu Y, et al.
J Gynecol Obstet Hum Reprod
. 2023 Mar;
52(4):102564.
PMID: 36868504
Purpose: To explore the diagnostic accuracy of ovarian solid tumors by 2D ultrasound and contrast-enhanced ultrasound (CEUS). Materials And Methods: We retrospectively evaluated the CEUS characteristics of prospectively enrolled 16...
9.
Shi T, Xiang L, Zhu J, Liu J, Zhang P, Wang H, et al.
J Gynecol Oncol
. 2022 Jul;
33(4):e63.
PMID: 35775688
No abstract available.
10.
Ge L, Li H, Du X, Zhu M, Chen W, Shi T, et al.
Biosens Bioelectron
. 2021 Dec;
200:113898.
PMID: 34968856
No abstract available.